163 related articles for article (PubMed ID: 26844860)
21. Current recommendations: Screening for Mendelian disorders.
Rose NC; Wick M
Semin Perinatol; 2016 Feb; 40(1):23-8. PubMed ID: 26706396
[TBL] [Abstract][Full Text] [Related]
22. How does carrier status for recessive disorders influence reproductive decisions? A systematic review of the literature.
Cannon J; Van Steijvoort E; Borry P; Chokoshvili D
Expert Rev Mol Diagn; 2019 Dec; 19(12):1117-1129. PubMed ID: 31709839
[No Abstract] [Full Text] [Related]
23. Unique considerations for genetic counseling in community-based carrier screening programs.
Rimoin DL; Greenwald S; Nathan TJ; Kaback MM
Prog Clin Biol Res; 1977; 18():297-304. PubMed ID: 601081
[No Abstract] [Full Text] [Related]
24. Pros and cons of implementing a carrier genetic test in an infertility practice.
Gil-Arribas E; Herrer R; Serna J
Curr Opin Obstet Gynecol; 2016 Jun; 28(3):172-7. PubMed ID: 27054511
[TBL] [Abstract][Full Text] [Related]
25. Professional norms in the practice of medical genetics.
Clarke JT
Health Law J; 1995; 3():131-51. PubMed ID: 10569872
[No Abstract] [Full Text] [Related]
26. Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.
Ferreira JC; Schreiber-Agus N; Carter SM; Klugman S; Gregg AR; Gross SJ
Am J Obstet Gynecol; 2014 Sep; 211(3):197-204. PubMed ID: 24508465
[TBL] [Abstract][Full Text] [Related]
27. A data-driven evaluation of the size and content of expanded carrier screening panels.
Ben-Shachar R; Svenson A; Goldberg JD; Muzzey D
Genet Med; 2019 Sep; 21(9):1931-1939. PubMed ID: 30816298
[TBL] [Abstract][Full Text] [Related]
28. Molecular biology techniques in the diagnosis of monogenic diseases.
Wagener C; Epplen JT; Ehrlich H; Peretz H; Vihko P
J Int Fed Clin Chem; 1994 Jun; 6(3):95-100. PubMed ID: 10147303
[TBL] [Abstract][Full Text] [Related]
29. Ethical and policy issues in genetic testing and screening of children.
; ; ; ; ;
Pediatrics; 2013 Mar; 131(3):620-2. PubMed ID: 23428972
[TBL] [Abstract][Full Text] [Related]
30. Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population.
Mathijssen IB; Holtkamp KCA; Ottenheim CPE; van Eeten-Nijman JMC; Lakeman P; Meijers-Heijboer H; van Maarle MC; Henneman L
Eur J Hum Genet; 2018 Feb; 26(2):166-175. PubMed ID: 29321671
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology.
Martin J; Asan ; Yi Y; Alberola T; Rodríguez-Iglesias B; Jiménez-Almazán J; Li Q; Du H; Alama P; Ruiz A; Bosch E; Garrido N; Simon C
Fertil Steril; 2015 Nov; 104(5):1286-93. PubMed ID: 26354092
[TBL] [Abstract][Full Text] [Related]
32. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
[TBL] [Abstract][Full Text] [Related]
33. Expanded Carrier Screening and the Complexity of Implementation.
Silver J; Norton ME
Obstet Gynecol; 2021 Feb; 137(2):345-350. PubMed ID: 33416279
[TBL] [Abstract][Full Text] [Related]
34. Genetic testing will bring interesting times to clinical practice.
Robin NH
Curr Opin Pediatr; 2004 Dec; 16(6):667-9. PubMed ID: 15548930
[No Abstract] [Full Text] [Related]
35. Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives.
Holtkamp KCA; Mathijssen IB; Lakeman P; van Maarle MC; Dondorp WJ; Henneman L; Cornel MC
Eur J Public Health; 2017 Apr; 27(2):372-377. PubMed ID: 27485720
[TBL] [Abstract][Full Text] [Related]
36. Genetic screening: survey of recent Halakhic periodical literature.
Bleich JD
Tradition; 2000; 34(1):63-87. PubMed ID: 11660816
[No Abstract] [Full Text] [Related]
37. On the testing load incurred by cascade genetic carrier screening for Mendelian disorders: a brief report.
Krawczak M; Caliebe A; Croucher PJ; Schmidtke J
Genet Test; 2007; 11(4):417-9. PubMed ID: 18294059
[TBL] [Abstract][Full Text] [Related]
38. A systematic analysis of online marketing materials used by providers of expanded carrier screening.
Chokoshvili D; Borry P; Vears DF
Genet Med; 2018 Sep; 20(9):976-984. PubMed ID: 29240075
[TBL] [Abstract][Full Text] [Related]
39. Human Genetics Society of Australasia Position Statement: Genetic Carrier Testing for Recessive Conditions.
Vears DF; Boyle J; Jacobs C; McInerney-Leo A; Newson AJ;
Twin Res Hum Genet; 2023 Apr; 26(2):188-194. PubMed ID: 37226803
[TBL] [Abstract][Full Text] [Related]
40. A clinical perspective on ethical issues in genetic testing.
Sijmons RH; Van Langen IM; Sijmons JG
Account Res; 2011 May; 18(3):148-62. PubMed ID: 21574071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
